AbCellera Biologics Insider Trading Activity | NASDAQ:ABCL

AbCellera Biologics Inc Insider Trading Activity

ABCLNASDAQ

Trade with Public

$3.76

0.12.73%

At close: Apr 13, 5:00 PM EST

$3.89

0.236.28%

Pre-Market: 4:52 AM EST

AbCellera Biologics Insider Trading Activity | NASDAQ:ABCL | Benzinga

Track the latest AbCellera Biologics insider trading activity. Stay informed on recent buys, sells, and market impact for AbCellera Biologics stock.

What is Insider Activity?

Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.

What are AbCellera Biologics Inc Insiders Doing?

Insiders have report no purchases/sales in the last 30 days.

Notable Recent Insider Buys and Sales

On February 27, 2026, Thermopylae Holdings Ltd, the company's 10% OWNER purchased 177.46K shares for 3.27 each.
On February 27, 2026, Andrew Booth, the company's CHIEF FINANCIAL OFFICER purchased 42.6K shares for 3.42 each.
On March 2, 2026, Thermopylae Holdings Ltd, the company's 10% OWNER purchased 38K shares for 3.44 each.

Ownership Statistics for AbCellera Biologics Inc

Shares Outstanding

299.335M

Shares Float

230777633.0%

Insider Shares Owned

4.900M

Insider Percentage Owned

1.62%

Institutional Shares Held

23.725M

Institutional Percentage Held

7.83%

Loading calendar...

FAQ

Is insider trading legal?

Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.

What are some examples of market manipulation?

Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.

ABCL Insider Trading News

AbCellera Biologics Form4 Filing Shows CFO Andrew Booth Bought 14,500 Shares At A Price Of $6.85/Share

- SEC Filing

Happy Mohamed

AbCellera Biologics Form4 Filing Shows Thermopylae Holdings Ltd. Bought 153,000 Shares At A Price Of $6.52/Share

- SEC Filing

Happy Mohamed

PRO
Abcellera Biologics Form 4 Filings From 10% Holder, Thermopylae Holdings, Shows Purchase Of 300K Shares On Friday, From Co. COO Shows Purchase Of 200K Shares

Benzinga Newsdesk

Insiders Including Co-founder Joe Gebbia, Selling Airbnb (ABNB) Despite The Recent Pullback

Insider selling is usually not a strong signal because insiders sell for a variety of reasons including the need to diversify their investments, to fund a large purchase, paying for a child’s education, etc. This has been confirmed by academic research over several decades and aligns with what I have seen during the last 12 years of tracking insider transactions every week.

Asif Suria

PRO
AbCellera Shares Spike To Session High, Quickly See Profit Taking Following Form 4 Showing Co. Director Bought ~87K Shares At Average Price $14.02/Share, Total Value $1.2M

Benzinga Newsdesk

People Also Watch

Agilent Technologies Inc